Shenzhen Shankang Pharmaceutical Technology Co., Ltd.
PrivateLast Round
VC Round
Jun 1, 2022
Est. Valuation
$459.04M
Total Funding Raised
$45.63M
Company Overview
Shenzhen Shankang Pharmaceutical Technology Co., Ltd. is a pharmaceutical company that develops addiction treatment drugs and long-acting drug delivery technologies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Mental Health
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Shenzhen Shankang Pharmaceutical Technology Co., Ltd. Comparables
Compare Shenzhen Shankang Pharmaceutical Technology Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Go Medical Industries | 78% | |
| Black Titan Corporation | 77% | |
| Akyso Therapeutics | 77% |
Shenzhen Shankang Pharmaceutical Technology Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jun 1, 2022 | ||||
| Series B | Aug 26, 2021 | ||||
| VC Round | Nov 1, 2019 |
Shenzhen Shankang Pharmaceutical Technology Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Huajin Capital | Series B |
| Xiaoxiang Capital Group | Series A |
| Shenzhen Yuanzhi Fuhai Investment Management | VC Round |
| Shenzhen Capital Group | Series B, Series A, VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 1, 2022
Raised $459M post-money valuation with Shenzhen Capital Group.
- Aug 26, 2021
$28.2M round led by Huajin Capital
Shenzhen Shankang Pharmaceutical Technology Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Shenzhen Shankang Pharmaceutical Technology Co., Ltd.'s valuation, stock price, and market status.
Is Shenzhen Shankang Pharmaceutical Technology Co., Ltd. a public or private company?
Shenzhen Shankang Pharmaceutical Technology Co., Ltd. is a private company.
What is the current stock price of Shenzhen Shankang Pharmaceutical Technology Co., Ltd.?
Shenzhen Shankang Pharmaceutical Technology Co., Ltd. is a private company with no public stock price. Caplight tracks Shenzhen Shankang Pharmaceutical Technology Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is Shenzhen Shankang Pharmaceutical Technology Co., Ltd. worth (valuation)?
Shenzhen Shankang Pharmaceutical Technology Co., Ltd.'s valuation is estimated at $459.0M based on funding round data.
Can I buy Shenzhen Shankang Pharmaceutical Technology Co., Ltd. stock?
Shenzhen Shankang Pharmaceutical Technology Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Shenzhen Shankang Pharmaceutical Technology Co., Ltd.'s last funding round?
Shenzhen Shankang Pharmaceutical Technology Co., Ltd.'s most recent funding round was VC Round on June 1, 2022.
Who are the main investors in Shenzhen Shankang Pharmaceutical Technology Co., Ltd.?
Key investors in Shenzhen Shankang Pharmaceutical Technology Co., Ltd. include Huajin Capital, Shenzhen Capital Group.
Will Shenzhen Shankang Pharmaceutical Technology Co., Ltd. IPO soon?
No public IPO plans have been announced for Shenzhen Shankang Pharmaceutical Technology Co., Ltd..
How can I track Shenzhen Shankang Pharmaceutical Technology Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Shenzhen Shankang Pharmaceutical Technology Co., Ltd.'s secondary market activity and sign up for updates.